Peanut Allergy Treatment Market
Peanut Allergy Treatment Market Forecasts to 2030 - Global Analysis By Treatment Type (Epinephrine, Antihistamines and Corticosteroids, Immunotherapy and Other Treatment Types), By Route Of Administration (Oral and Injectable), End User and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $516.1 MN |
|
Projected Year Value (2030) |
US $1,169.8 MN |
|
CAGR (2023-2030) |
12.4% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Europe |
According to Stratistics MRC, the Global Peanut Allergy Treatment Market is accounted for $516.1 million in 2023 and is expected to reach $1169.8 million by 2030 growing at a CAGR of 12.4% during the forecast period. Peanut allergy treatment involves various strategies to manage and alleviate allergic reactions triggered by the consumption of peanuts. Approaches include allergen avoidance, emergency interventions with epinephrine, and allergen immunotherapy, aimed at desensitizing the immune system. These treatments aim to enhance patient safety, minimize allergic responses, and improve the overall quality of life for individuals with peanut allergies.
According to the ITC trade map, in 2021, Argentina exported 634,080 metric ton of peanuts, followed by India with 563,268 metric ton in second place.
Market Dynamics:
Driver:
Increasing prevalence of peanut allergy
With a rising number of individuals diagnosed with peanut allergies globally, there is a growing need for effective treatment options. This trend propels research and development efforts towards innovative therapies, including allergen immunotherapy, emergency interventions, and preventive measures. Moreover, the expanding patient pool fosters market growth as pharmaceutical companies and healthcare providers address the demand for advanced and accessible treatments to manage and mitigate the risks associated with peanut allergies.
Restraint:
High cost of treatment
Expenses associated with allergen immunotherapy, emergency interventions, and ongoing medical management contribute to the financial burden on patients and healthcare systems. Limited insurance coverage for certain treatments further exacerbates the cost barrier. This high financial threshold may deter some individuals from seeking or continuing treatment, impacting overall patient adherence and outcomes.
Opportunity:
Rising awareness and diagnosis rates
Increased awareness among healthcare professionals and the general public about peanut allergies leads to early detection and diagnosis. As awareness grows, more individuals seek medical attention, creating a larger patient pool for treatment options. This trend not only improves patient outcomes by enabling timely interventions but also drives the demand for effective peanut allergy treatments. Pharmaceutical companies and healthcare providers can capitalize on this opportunity by developing innovative treatments, fostering education initiatives, and contributing to a more comprehensive understanding of peanut allergies in both medical communities and the public.
Threat:
Limited access to specialists and treatment centers
Limited access to specialists and treatment centers poses a significant threat to the peanut allergy treatment market. Patients facing peanut allergies may encounter challenges in accessing specialized healthcare professionals and designated treatment facilities. This limitation can hinder timely diagnosis, personalized treatment plans, and the administration of allergen immunotherapy. The scarcity of trained specialists may contribute to gaps in patient care, impacting the effectiveness of interventions.
Covid-19 Impact:
The COVID-19 pandemic has impacted the peanut allergy treatment market by causing disruptions in healthcare services, including allergy diagnostics and treatments. Lockdowns, restrictions, and shifts in healthcare priorities led to delays in patient care, diagnosis, and treatment initiation. Additionally, the pandemic affected clinical trials and research activities, influencing the overall landscape of peanut allergy treatment. As the situation stabilizes, the market is gradually recovering, with an increased emphasis on patient safety and innovative treatment approaches.
The Immunotherapies segment is expected to be the largest during the forecast period
The immunotherapies segment is anticipated to be the largest in the peanut allergy treatment market during the forecast period. This dominance is attributed to the increasing adoption of allergen immunotherapy, including subcutaneous and sublingual approaches, aimed at desensitizing the immune system to peanuts. With a focus on addressing the root cause of peanut allergies and reducing allergic reactions, immunotherapies emerge as a preferred treatment option, contributing to the segment's substantial market share growth.
The injectable segment is expected to have the highest CAGR during the forecast period
The injectable segment is projected to experience lucrative growth in the peanut allergy treatment market during the forecast period. This growth is driven by the increasing preference for injectable forms of treatment, particularly the use of epinephrine auto-injectors for emergency management of severe allergic reactions. With a heightened focus on rapid and efficient intervention during allergic emergencies, the injectable segment is poised for substantial growth, offering a convenient and effective solution for patients and caregivers.
Region with largest share:
North America is poised to dominate the peanut allergy treatment market due to advanced healthcare infrastructure, heightened awareness of peanut allergies, and a proactive regulatory environment. The region's focus on innovative therapies, including immunotherapies, and a higher prevalence of peanut allergies contribute to its market leadership. Additionally, collaborations between healthcare organizations and research institutions further drive advancements in peanut allergy treatment, positioning North America as a key hub for developments and market dominance.
Region with highest CAGR:
The European region foresees rapid growth in the peanut allergy treatment market due to the increasing prevalence of peanut allergies, a strong emphasis on healthcare research, and advancements in treatment options. Rising awareness among healthcare professionals and patients, coupled with supportive regulatory frameworks, propels the adoption of innovative peanut allergy therapies. As research and development efforts intensify, Europe emerges as a significant contributor to advancements in peanut allergy treatment, driving substantial market growth in the forecasted period.
Key players in the market
Some of the key players in Peanut Allergy Treatment Market include Aimmune Therapeutics, ALK-Abelló A/S, Alladapt Immunotherapeutics, Inc, AnaptysBio, Inc., DBV Technologies SA, GlaxoSmithKline plc, HAL Allergy Group, Merck & Co., Inc., Mylan N.V., Novartis AG, Pfizer Inc., Prota Therapeutics, Regeneron Pharmaceuticals, Sanofi and Stallergenes Greer.
Key Developments:
In June 2023, Alladapt Immunotherapeutics, Inc. has unveiled topline results of Phase 1/2 Harmony study assessing effectiveness & safety of ADP101 for treating food allergies. Outcomes indicate dose-dependent, clinically significant responses, and a favorable safety profile in pediatric patients with single or multiple food allergies. These promising findings suggest ADP101's potential as a safe and effective treatment for children with common food allergies.
In May 2023, DBV Technologies has made an announcement that the results of its Phase 3 EPITOPE trial involving EPIT using Viaskin Peanut in children aged 1 to 3 years have been published in the New England Journal of Medicine. This publication underscores the potential of a new food allergy treatment option for this specific age group, offering hope for the management of food allergies in young children.
Treatment Types Covered:
• Epinephrine
• Antihistamines and Corticosteroids
• Immunotherapy
• Other Treatment Types
Route of Administrations Covered:
• Oral
• Injectable
End Users Covered:
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Homecare Settings
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Peanut Allergy Treatment Market, By Treatment Type
5.1 Introduction
5.2 Epinephrine
5.3 Antihistamines and Corticosteroids
5.4 Immunotherapy
5.5 Other Treatment Types
6 Global Peanut Allergy Treatment Market, By Route Of Administration
6.1 Introduction
6.2 Oral
6.3 Injectable
7 Global Peanut Allergy Treatment Market, By End User
7.1 Introduction
7.2 Hospitals
7.3 Clinics
7.5 Ambulatory Surgical Centers
7.6 Homecare Settings
8 Global Peanut Allergy Treatment Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Aimmune Therapeutics
10.2 ALK-Abelló A/S
10.3 Alladapt Immunotherapeutics, Inc
10.4 AnaptysBio, Inc.
10.5 DBV Technologies SA
10.6 GlaxoSmithKline plc
10.7 HAL Allergy Group
10.8 Merck & Co., Inc.
10.9 Mylan N.V.
10.10 Novartis AG
10.11 Pfizer Inc.
10.12 Prota Therapeutics
10.13 Regeneron Pharmaceuticals
10.14 Sanofi
10.15 Stallergenes Greer
List of Tables
1 Global Peanut Allergy Treatment Market Outlook, By Region (2021-2030) ($MN)
2 Global Peanut Allergy Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
3 Global Peanut Allergy Treatment Market Outlook, By Epinephrine (2021-2030) ($MN)
4 Global Peanut Allergy Treatment Market Outlook, By Antihistamines and Corticosteroids (2021-2030) ($MN)
5 Global Peanut Allergy Treatment Market Outlook, By Immunotherapy (2021-2030) ($MN)
6 Global Peanut Allergy Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
7 Global Peanut Allergy Treatment Market Outlook, By Route Of Administration (2021-2030) ($MN)
8 Global Peanut Allergy Treatment Market Outlook, By Oral (2021-2030) ($MN)
9 Global Peanut Allergy Treatment Market Outlook, By Injectable (2021-2030) ($MN)
10 Global Peanut Allergy Treatment Market Outlook, By End User (2021-2030) ($MN)
11 Global Peanut Allergy Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
12 Global Peanut Allergy Treatment Market Outlook, By Clinics (2021-2030) ($MN)
13 Global Peanut Allergy Treatment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
14 Global Peanut Allergy Treatment Market Outlook, By Homecare Settings (2021-2030) ($MN)
15 North America Peanut Allergy Treatment Market Outlook, By Country (2021-2030) ($MN)
16 North America Peanut Allergy Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
17 North America Peanut Allergy Treatment Market Outlook, By Epinephrine (2021-2030) ($MN)
18 North America Peanut Allergy Treatment Market Outlook, By Antihistamines and Corticosteroids (2021-2030) ($MN)
19 North America Peanut Allergy Treatment Market Outlook, By Immunotherapy (2021-2030) ($MN)
20 North America Peanut Allergy Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
21 North America Peanut Allergy Treatment Market Outlook, By Route Of Administration (2021-2030) ($MN)
22 North America Peanut Allergy Treatment Market Outlook, By Oral (2021-2030) ($MN)
23 North America Peanut Allergy Treatment Market Outlook, By Injectable (2021-2030) ($MN)
24 North America Peanut Allergy Treatment Market Outlook, By End User (2021-2030) ($MN)
25 North America Peanut Allergy Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
26 North America Peanut Allergy Treatment Market Outlook, By Clinics (2021-2030) ($MN)
27 North America Peanut Allergy Treatment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
28 North America Peanut Allergy Treatment Market Outlook, By Homecare Settings (2021-2030) ($MN)
29 Europe Peanut Allergy Treatment Market Outlook, By Country (2021-2030) ($MN)
30 Europe Peanut Allergy Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
31 Europe Peanut Allergy Treatment Market Outlook, By Epinephrine (2021-2030) ($MN)
32 Europe Peanut Allergy Treatment Market Outlook, By Antihistamines and Corticosteroids (2021-2030) ($MN)
33 Europe Peanut Allergy Treatment Market Outlook, By Immunotherapy (2021-2030) ($MN)
34 Europe Peanut Allergy Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
35 Europe Peanut Allergy Treatment Market Outlook, By Route Of Administration (2021-2030) ($MN)
36 Europe Peanut Allergy Treatment Market Outlook, By Oral (2021-2030) ($MN)
37 Europe Peanut Allergy Treatment Market Outlook, By Injectable (2021-2030) ($MN)
38 Europe Peanut Allergy Treatment Market Outlook, By End User (2021-2030) ($MN)
39 Europe Peanut Allergy Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
40 Europe Peanut Allergy Treatment Market Outlook, By Clinics (2021-2030) ($MN)
41 Europe Peanut Allergy Treatment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
42 Europe Peanut Allergy Treatment Market Outlook, By Homecare Settings (2021-2030) ($MN)
43 Asia Pacific Peanut Allergy Treatment Market Outlook, By Country (2021-2030) ($MN)
44 Asia Pacific Peanut Allergy Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
45 Asia Pacific Peanut Allergy Treatment Market Outlook, By Epinephrine (2021-2030) ($MN)
46 Asia Pacific Peanut Allergy Treatment Market Outlook, By Antihistamines and Corticosteroids (2021-2030) ($MN)
47 Asia Pacific Peanut Allergy Treatment Market Outlook, By Immunotherapy (2021-2030) ($MN)
48 Asia Pacific Peanut Allergy Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
49 Asia Pacific Peanut Allergy Treatment Market Outlook, By Route Of Administration (2021-2030) ($MN)
50 Asia Pacific Peanut Allergy Treatment Market Outlook, By Oral (2021-2030) ($MN)
51 Asia Pacific Peanut Allergy Treatment Market Outlook, By Injectable (2021-2030) ($MN)
52 Asia Pacific Peanut Allergy Treatment Market Outlook, By End User (2021-2030) ($MN)
53 Asia Pacific Peanut Allergy Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
54 Asia Pacific Peanut Allergy Treatment Market Outlook, By Clinics (2021-2030) ($MN)
55 Asia Pacific Peanut Allergy Treatment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
56 Asia Pacific Peanut Allergy Treatment Market Outlook, By Homecare Settings (2021-2030) ($MN)
57 South America Peanut Allergy Treatment Market Outlook, By Country (2021-2030) ($MN)
58 South America Peanut Allergy Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
59 South America Peanut Allergy Treatment Market Outlook, By Epinephrine (2021-2030) ($MN)
60 South America Peanut Allergy Treatment Market Outlook, By Antihistamines and Corticosteroids (2021-2030) ($MN)
61 South America Peanut Allergy Treatment Market Outlook, By Immunotherapy (2021-2030) ($MN)
62 South America Peanut Allergy Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
63 South America Peanut Allergy Treatment Market Outlook, By Route Of Administration (2021-2030) ($MN)
64 South America Peanut Allergy Treatment Market Outlook, By Oral (2021-2030) ($MN)
65 South America Peanut Allergy Treatment Market Outlook, By Injectable (2021-2030) ($MN)
66 South America Peanut Allergy Treatment Market Outlook, By End User (2021-2030) ($MN)
67 South America Peanut Allergy Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
68 South America Peanut Allergy Treatment Market Outlook, By Clinics (2021-2030) ($MN)
69 South America Peanut Allergy Treatment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
70 South America Peanut Allergy Treatment Market Outlook, By Homecare Settings (2021-2030) ($MN)
71 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Country (2021-2030) ($MN)
72 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
73 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Epinephrine (2021-2030) ($MN)
74 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Antihistamines and Corticosteroids (2021-2030) ($MN)
75 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Immunotherapy (2021-2030) ($MN)
76 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
77 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Route Of Administration (2021-2030) ($MN)
78 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Oral (2021-2030) ($MN)
79 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Injectable (2021-2030) ($MN)
80 Middle East & Africa Peanut Allergy Treatment Market Outlook, By End User (2021-2030) ($MN)
81 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
82 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Clinics (2021-2030) ($MN)
83 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
84 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Homecare Settings (2021-2030) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
